NRC HEALTH director granted 7,697 RSUs

NUNNELLY JOHN N reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

NUNNELLY JOHN N reported acquisition or exercise transactions in this Form 4 filing.

NRC HEALTH director John N. Nunnelly received an equity award of 7,697 restricted stock units of Common Stock as annual compensation. The grant represents $150,000 of value, calculated using the closing share price before the company’s 2026 annual stockholder meeting. After this award, he holds 40,363 shares directly. The restricted stock units will vest and become exercisable on the date of the company’s 2027 annual stockholder meeting, subject to standard vesting, forfeiture, and termination conditions.

Insider Trade Summary

Grant/Award: 7,697 shares

Grant/Award 1 txn

Insider NUNNELLY JOHN N

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	7,697	$0.00	$0.00

Holdings After Transaction: Common Stock — 40,363 shares (Direct)

Footnotes (1)

1. F1. This share award represents annual equity compensation in the form of a grant of restricted stock units equal to $150,000, divided by the closing price on the date immediately preceding the Issuer's 2026 annual meeting of stockholders, under the Issuer's 2025 Omnibus Incentive Plan. The award will vest and become exercisable on the date of the Issuer's 2027 annual stockholder meeting, subject to vesting, forfeiture, and termination provisions.

Key Figures

Equity award size: 7,697 units Award value: $150,000 Transaction price per share: $0.0000 +2 more

5 metrics

Equity award size 7,697 units Restricted stock units of Common Stock granted as annual compensation

Award value $150,000 Equity compensation value used to determine number of restricted stock units

Transaction price per share $0.0000 Non-cash grant of restricted stock units

Shares owned after grant 40,363 shares Total direct ownership of NRC HEALTH Common Stock following the transaction

Vesting date 2027 annual meeting Restricted stock units vest on the date of the 2027 stockholder meeting

Key Terms

restricted stock units, annual equity compensation, 2025 Omnibus Incentive Plan, vesting, +1 more

5 terms

restricted stock units financial

"This share award represents annual equity compensation in the form of a grant of restricted stock units equal to $150,000"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

annual equity compensation financial

"This share award represents annual equity compensation in the form of a grant of restricted stock units"

2025 Omnibus Incentive Plan financial

"under the Issuer's 2025 Omnibus Incentive Plan"

An omnibus incentive plan is a company-wide program that authorizes awards of pay tied to performance and retention—such as stock options, restricted shares, cash bonuses and other rewards—here labeled for the year it was adopted (2025). Investors care because it affects how much ownership can be issued, dilutes existing shareholders, and aligns executives’ and employees’ incentives with company goals, similar to giving team members a stake in the outcome.

vesting financial

"The award will vest and become exercisable on the date of the Issuer's 2027 annual stockholder meeting"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

forfeiture financial

"subject to vesting, forfeiture, and termination provisions"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did NRC (NRC) director John N. Nunnelly report in this Form 4?

John N. Nunnelly reported receiving 7,697 restricted stock units of NRC HEALTH Common Stock as annual equity compensation. The award is valued at $150,000 and was granted at no cash cost to him under the company’s 2025 Omnibus Incentive Plan.

How was the value of John N. Nunnelly’s NRC (NRC) equity award determined?

The equity award was set at $150,000, divided by NRC HEALTH’s closing share price on the trading day immediately before the 2026 annual stockholder meeting. That calculation produced 7,697 restricted stock units reported as Common Stock on the Form 4.

When do John N. Nunnelly’s NRC (NRC) restricted stock units vest?

The restricted stock units will vest and become exercisable on the date of NRC HEALTH’s 2027 annual stockholder meeting. Vesting remains subject to the plan’s vesting, forfeiture, and termination provisions described in the award terms under the 2025 Omnibus Incentive Plan.

How many NRC (NRC) shares does John N. Nunnelly hold after this transaction?

Following this equity grant, John N. Nunnelly is reported as directly owning 40,363 shares of NRC HEALTH Common Stock. This total includes the newly awarded restricted stock units as disclosed in the Form 4 filing’s post-transaction ownership figure.

Did John N. Nunnelly pay cash for his NRC (NRC) restricted stock units?

No cash was paid for the award; the transaction price per share is reported as 0.0000. The 7,697 restricted stock units represent non-cash annual equity compensation valued at $150,000, granted under NRC HEALTH’s 2025 Omnibus Incentive Plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/25/2026 - 04:39 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

NUNNELLY JOHN N

(Last) (First) (Middle)

P. O. BOX 2175

(Street)

AMHERST MASSACHUSETTS 01004

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
NRC HEALTH [ NRC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/23/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/23/2026		A		7,697(1)	A(1)	$0	40,363	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This share award represents annual equity compensation in the form of a grant of restricted stock units equal to $150,000, divided by the closing price on the date immediately preceding the Issuer's 2026 annual meeting of stockholders, under the Issuer's 2025 Omnibus Incentive Plan. The award will vest and become exercisable on the date of the Issuer's 2027 annual stockholder meeting, subject to vesting, forfeiture, and termination provisions.

	/s/ John N. Nunnelly, by Christopher Kortum, attorney-in-fact, pursuant to a POA previously filed with the SEC	06/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)